Other
Dental Implant
1
Pipeline Programs↗
9
Active Trials↗
3
Companies Involved↗
Dental Implant is an early-stage landscape with 1 program across 3 companies. The most active players are OraPharma, Zeliha Başak Çakır Erdil, International Dental Contiuing Education.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
38
clinical trials
Completed19 · 50%
Unknown status9 · 24%
Not yet recruiting4 · 11%
Recruiting3 · 8%
Active, not recruiting2 · 5%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
38 trials
Impact of Biological Factors on Dental Implant
Not yet recruiting·—·N/A·NCT06037070·10 enrolled
Influence of Human Platelet Derivatives on Dental Implant
Not yet recruiting·—·N/A·NCT06044246·30 enrolled
Clinical Study to Investigate a New Mouthwash in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use
Completed·—·Phase 3·NCT06770114·80 enrolled
Effect of Locally Applied Simvastatin Gel on Dental Implant Stability and Marginal Bone Level
Completed·—·N/A·NCT07194447·42 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)